Remote Sensing for ADRD-Specific Activities Identification in Older Adults
Eligible age
50+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The investigators aim to use smart-home sensors and artificial intelligence (AI) to monitor and detect Alzheimer's Disease and Related Dementias (ADRD)-specific daily activities among older adults, with the goal of early symptom detection and personalized support. Dementia, which impacts memory and cognition, remains a global concern. In the United States, more than 6.7 million individuals aged 65 and older are living with ADRD, and projected annual healthcare costs are expected to reach $1 trillion by 2050. This underscores the need for deeper understanding and innovative support. To address the unique challenges associated with ADRD, such as cognitive decline, personalized strategies that promote independent well-being are essential. Smart-home sensors can support older adults with ADRD as they continue to live in their homes. These sensors provide real-time data on health and daily activities, offering insights into their daily lives. However, adoption of these technologies is low, and the practical application of AI remains limited. This highlights the need for further research to make these devices more accessible to this population. The investigators' aims include: Conducting focus groups with individuals with and without ADRD and their caregivers to identify daily activities that can be measured using in-home sensors; Collecting in-home sensor data from older adults with and without ADRD; and Using AI to develop a tool for recognizing daily activities. The integration of smart-home sensors with advanced data-analysis techniques holds significant potential for transforming the support and care provided to individuals with ADRD. Ultimately, the investigators' findings will contribute to improving the quality of life for affected individuals and alleviating the burden on caregivers and healthcare systems.
Sponsor: University of Missouri-Columbia
You may qualify if…
- ✓ Community-dwelling, English-speaking adults aged ≥ 50 years
- ✓ Clinical diagnosis of mild cognitive impairment or mild dementia (ADRD)
- ✓ Diagnosis established by a neuropsychologist, neurologist, or geriatrician within the University of Missouri Healthcare System
- ✓ Diagnosis confirmed using the latest consensus criteria and verified through record review
- ✓ No restriction on the etiology of the cognitive disorder (e.g., Alzheimer's disease, vascular dementia, mixed dementia)
You may not qualify if…
- ✕ Clinical Dementia Rating (CDR) global score \> 1 (moderate or severe dementia)
- ✕ Cognitive or functional impairments that would preclude meaningful participation in daily activities
Where it's recruiting
Columbia
Source: ClinicalTrials.gov · NCT07120347 · last updated 2025-08-13